You are here: Industry Insights > brain cancer

News List

Henry Ford Cancer Institute Enrolls First Patient in Brain Cancer Clinical Trial americanpharmaceuticalreview
August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a patient in the GBM AGILE Trial (Adaptive Global Innovative Learning Environment) – a novel trial design and architecture made possible by an international collaboration of experts in ...
Kazia Therapeutics calls for greater awareness of brain cancer in the US biospectrumasia
July 20, 2019
Kazia is developing a drug called GDC-0084 for the treatment of Glioblastoma (GBM) and other cancers, which was licensed from US pharmaceutical group, Genentech and is currently in phase II human trials
Potential first ever targeted therapy designed for ‘untreatable’ childhood brain cancer pharmatimes
May 12, 2019
Scientists at The Institute of Cancer Research, London have discovered a new type of drug that targets a genetic weakness in ‘diffuse intrinsic pontine glioma’ (DIPG), an untreatable childhood brain cancer, which could become the first ever treatment desi
Protein content as a marker for response to therapy in brain cancer worldpharmanews
March 06, 2019
Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient.
Nature publication reports first-in-human trial of a novel actively personalized therapeutic vaccine for brain cancer firstwordpharma
December 25, 2018
The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent publication in Nature of favorable data from the phase 1 study GAPVAC-101, testing a novel therapeutic concept tailored to specific
Zika vaccine shows potential for brain cancer treatment pharmaceutical-technology
September 21, 2018
Researchers at the University of Texas Medical Branch at Galveston (UTMB) in the US have used a Zika vaccine, currently in the development phase, to treat a deadly brain cancer called glioblastoma.
Drug-delivering nanoparticles could help fight brain cancer europeanpharmaceuticalreview
May 30, 2018
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumours…
A novel immuno-oncology approach to treating a rare childhood brain cancer fiercebiotech
December 05, 2017
rare type of childhood brain tumor called diffuse intrinsic pontine glioma (DIPG) has a distinct characteristic that may prove to be its undoing—a misshapen protein displayed prominently on the surfaces of its cells.
Arsenic identified as a potential treatment for brain cancer europeanpharmaceuticalreview
October 19, 2017
Arsenic trioxide could extend survival of some glioblastoma patients by three to four times the historic median…
Surprising link between blood sugar, brain cancer found biospectrumasia
May 15, 2017
New research further illuminates the surprising relationship between blood sugar and brain tumors and could begin to shed light on how certain cancers develop

Previous page 1 2 3 Next page